Last reviewed · How we verify
brilliant green
At a glance
| Generic name | brilliant green |
|---|---|
| Drug class | brilliant green |
| Therapeutic area | Infectious Disease |
| Phase | FDA-approved |
Approved indications
- Infection protection
Common side effects
Key clinical trials
- Mechanical Properties of the Internal Limiting Membrane and Intraoperative Utility of Brilliant Blue g (Bbg) and Indocyanine Green (Icg) Assisted Chromovitrectomy
- Patients' Quality of Life After Pilonidal Cyst Operations. (NA)
- Comparison of Laser Destruction of Pilonidal Sinus Disease (SILAC) and Bascom II Procedure. (NA)
- Infracyanine Green vs Brilliant Blue G in Macular Hole Inverted Flap Surgery: A Swept Source OCT Analysis. (NA)
- Brillant Blue Versus Indocyanine Green for Macular Hole Surgery (NA)
- Brilliant Blue Versus Indocyanine Green (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- brilliant green CI brief — competitive landscape report
- brilliant green updates RSS · CI watch RSS
- portfolio CI